Combining dalfampridine with physical therapy to improve walking in multiple sclerosis
Official title: Dalfampridine Combined With Physical Therapy for Mobility Impairment in People With Multiple Sclerosis
Run by MGH Institute of Health Professions · NCT06136728 · Data updated 2026-11-12
This study is testing if taking dalfampridine along with physical therapy can help people with multiple sclerosis walk better than just using physical therapy alone.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 25 Years to 75 Years |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | MGH Institute of Health Professions Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | September 20, 2024 |
| Main results expected | May 2027 |
| Study ends | July 2027 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT06136728 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with multiple sclerosis who have mobility impairments and meet specific eligibility criteria.
✕Probably not a fit
Patients with co-existing neurological disorders, orthopedic conditions affecting mobility, or those currently receiving physical therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of combining dalfampridine, a medication that enhances walking ability, with a structured physical therapy program in individuals with mobility impairments due to multiple sclerosis (MS). Participants will undergo a 6-week treatment with dalfampridine, followed by a 2-week washout period, after which they will be randomly assigned to receive either physical therapy alone or physical therapy in conjunction with dalfampridine. The study will compare the outcomes of the combined treatment against each individual treatment to determine the most effective approach for improving mobility in MS patients.
Why it matters
Potential benefit: If successful, this approach could significantly enhance mobility and quality of life for patients with multiple sclerosis.
How similar studies have gone: Previous studies have shown positive outcomes with physical therapy in MS, but the combination with dalfampridine is a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed diagnosis of MS * Expanded Disability Status Scale (EDSS) 6.5 or less * Timed 25-Foot Walk 6-45 seconds (average of 2 trials) * Able to stand unsupported for at least 10 seconds * Montreal Cognitive Assessment 23 or higher * Relapse free for at least 3 months * Not currently taking dalfampridine or not previously taken and discontinued due to adverse reactions * Not currently receiving physical therapy Exclusion Criteria: * Co-existing neurological disorders or orthopedic conditions affecting mobility and physical activity * Unable to follow a 3-step verbal command in English * Hospitalization for any reason in the last 3 months * Uncontrolled hypertension or diabetes * History of seizures * Renal impairment * Women who are breastfeeding, pregnant, or trying to become pregnant * Contraindications to magnetic resonance imaging (MRI; to be excluded from MRI procedures but may participate if all other criteria are met)
Where it's running
-
MGH Institute of Health Professions
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Prudence Plummer, PhD, PT — MGH Institute of Health Professions
- Study coordinator: Prudence Plummer, PhD
- Email: pplummer@mghihp.edu
- Phone: 617-724-3103
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.